Naveen Kumar Devanga Ragupathi
Overview
Explore the profile of Naveen Kumar Devanga Ragupathi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wannigama D, Sithu Shein A, Hurst C, Monk P, Hongsing P, Phattharapornjaroen P, et al.
iScience
. 2023 Jul;
26(7):107215.
PMID: 37496674
Developing an effective therapy to overcome carbapenemase-positive (CPKp) is an important therapeutic challenge that must be addressed urgently. Here, we explored a Ca-EDTA combination with aztreonam or ceftazidime-avibactam and against...
12.
Wannigama D, Amarasiri M, Phattharapornjaroen P, Hurst C, Modchang C, Chadsuthi S, et al.
J Travel Med
. 2023 Jul;
30(5).
PMID: 37462504
High population density and tourism in Southeast Asia increase the risk of mpox due to frequent interpersonal contacts. Our wastewater surveillance in six Southeast Asian countries revealed positive signals for...
13.
Wannigama D, Amarasiri M, Hongsing P, Hurst C, Modchang C, Chadsuthi S, et al.
iScience
. 2023 Jun;
26(7):107019.
PMID: 37351501
Equitable SARS-CoV-2 surveillance in low-resource communities lacking centralized sewers is critical as wastewater-based epidemiology (WBE) progresses. However, large-scale studies on SARS-CoV-2 detection in wastewater from low-and middle-income countries is limited...
14.
Siddiqui S, Hodeify R, Mathew S, Alsawaf S, Alghfeli A, Matar R, et al.
Inflammopharmacology
. 2023 May;
31(4):2049-2060.
PMID: 37204695
Cyclosporine A (CsA) is an immunosuppressant primarily used at a higher dosage in transplant medicine and autoimmune diseases with a higher success rate. At lower doses, CsA exhibits immunomodulatory properties....
15.
Ragupathi N, Muthuirulandi Sethuvel D, Gopikrishnan M, Dwarakanathan H, Murugan D, Biswas I, et al.
Microb Pathog
. 2023 Mar;
178:106064.
PMID: 36898591
Persistent antibiotic use results in the rise of antimicrobial resistance with limited or no choice for multidrug-resistant (MDR) and extensively drug resistant (XDR) bacteria. This necessitates a need for alternative...
16.
Wannigama D, Amarasiri M, Hongsing P, Hurst C, Modchang C, Chadsuthi S, et al.
Sci Total Environ
. 2022 Dec;
858(Pt 1):159816.
PMID: 36461562
The monkeypox virus is excreted in the feces of infected individuals. Therefore, there is an interest in using viral load detection in wastewater for sentinel early surveillance at a community...
17.
Ragupathi N, Veeraraghavan B, Karunakaran E, Monk P
Front Med (Lausanne)
. 2022 Aug;
9:987011.
PMID: 35979211
No abstract available.
18.
Sithu Shein A, Wannigama D, Higgins P, Hurst C, Abe S, Hongsing P, et al.
Sci Rep
. 2022 Jul;
12(1):12939.
PMID: 35902639
The global prevalence of colistin-resistant Klebsiella pneumoniae (ColRkp) facilitated by chromosomal and plasmid-mediated Ara4N or PEtN-remodeled LPS alterations has steadily increased with increased colistin usage for treating carbapenem-resistant K. pneumoniae...
19.
Sithu Shein A, Hongsing P, Abe S, Luk-In S, Ragupathi N, Wannigama D, et al.
Front Med (Lausanne)
. 2022 Jan;
8:806849.
PMID: 35004783
No abstract available.
20.
Ragupathi N, Muthuirulandi Sethuvel D, Murugan D, Ranjan R, Gautam V, Gupta P, et al.
PLoS One
. 2021 Dec;
16(12):e0261435.
PMID: 34910778
Diphtheria is caused by a toxigenic bacterium Corynebacterium diphtheria which is being an emerging pathogen in India. Since diphtheria morbidity and mortality continues to be high in the country, the...